COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,895 Articles (22,568 medRxiv, 8,327 bioRxiv)

Most recent first Previous |  Page 1819: Articles 18181-18190  | Next

Multinational Prevalence of Neurological Phenotypes in Patients Hospitalized with COVID-19
Le, T. T., Gutierrez-Sacristan, A., Son, J., Hong, C., South, A. M., Beaulieu-Jones, B. K., Loh, N. H. W., Luo, Y., Morris, M., Ngiam, K. Y., Patel, L. P., Samayamuthu, M. J., Schriver, E., Tan, A. L., Moore, J., Cai, T., Omenn, G. S., Avillach, P., Kohane, I. S., The Consortium for Clinical Characterization of COVID-19 by EHR (4CE), , Visweswaran, S., Mowery, D. L., Xia, Z.
10.1101/2021.01.27.21249817 — Posted: 2021-01-29
Depression Symptoms during the COVID-19 Pandemic among Well-Educated, Employed Adults with Low Infection Risks
Thomas, D., Brown, T., Taylor, D. H., Lawton, R., Lee, V. K., Mburi, M., Wong, M., Kranton, R.
10.1101/2021.01.26.21250558 — Posted: 2021-01-29
Risk perception of COVID-19 and its socioeconomic correlates in the United States: A social media analysis
Qiao, S., Li, Z., Liang, C., Li, X., Rudisill, C. A.
10.1101/2021.01.27.21250654 — Posted: 2021-01-29
Reduction of respiratory syncytial virus burden of disease observed in primary care diagnosis of children under 5 years old during the COVID-19 pandemic: a time-series analysis using routinely collected data from primary care electronic health records in Catalonia (Spain).
Coma, E., Vila, J., Mendez-Boo, L., Anton, A., Mora, N., Fina, F., Fabregas, M., Medina, M.
10.1101/2021.01.27.21250063 — Posted: 2021-01-29
Stringency of the containment measures in response to COVID-19 inversely correlates with the overall disease occurrence over the epidemic wave
Mezencev, R., Klement, C.
10.1101/2021.01.26.21250501 — Posted: 2021-01-29
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Letizia, A. G., Ge, Y., Vangeti, S., Goforth, C., Weir, D. L., Kuzmina, N. A., Chen, H. W., Ewing, D., Soares-Schanoski, A., George, M.-C., Graham, W. D., Jones, F., Bharaj, P., Lizewski, R. A., Lizewski, S. A., Marayag, J., Marjanovic,, N., Miller, C., Mofsowitz, S., Nair, V. D., Nunez, E., Parent, D. M., Porter, C. K., Santa Ana, E., Schilling, M., Stadlbauer, D., Sugiharto, V., Termini, M. S., Sun, P., Tracy, R. P., Krammer, F., Bukreyev, A., Irene, R., Sealfon, S. C.
10.1101/2021.01.26.21250535 — Posted: 2021-01-29
Covid-19 positive test cycle threshold trends predict covid-19 mortality in Rhode Island
Bostom, A., Eaton, C. B., Kenyon, T.
10.1101/2021.01.26.21250557 — Posted: 2021-01-29
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Personalized Virology Initiative (PVI) Study Group, , Krammer, F., Simon, V., Martinez-Sobrido, L., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.26.21250543 — Posted: 2021-01-29
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study
Theuring, S., Thielecke, M., van Loon, W., Hommes, F., Huelso, C., von der Haar, A., Koerner, J., Schmidt, M., Boehringer, F., Mall, M. A., Rosen, A., von Kalle, C., Kirchberger, V., Kurth, T., Seybold, J., Mockenhaupt, F. P., BECOSS Study Group
10.1101/2021.01.27.21250517 — Posted: 2021-01-29 Discussion: Offsite
Evaluation of spike protein antigens for SARS-CoV-2 serology
Jagtap, S., K, R., Valloly, P., Sharma, R., Maurya, S., Gaigore, A., Ardhya, C., Biligi, D. S., Desiraju, B. K., Natchu, U. C. M., Saini, D. K., Roy, R.
10.1101/2021.01.27.21250382 — Posted: 2021-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).